8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-001239
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading xfor-20250113.htm…